A Phase I Trial Combining Decitabine and Vaccine Therapy for Patients With Relapsed Neuroblastoma and Sarcoma
Phase of Trial: Phase I
Latest Information Update: 11 May 2017
At a glance
- Drugs Decitabine (Primary) ; Dendritic cell vaccines; Imiquimod
- Indications Ewing's sarcoma; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Synovial sarcoma
- Focus Adverse reactions
- 07 Jun 2017 Biomarkers information updated
- 05 Oct 2016 Status changed from active, no longer recruiting to completed.
- 27 Sep 2016 Planned End Date changed from 1 Dec 2016 to 1 Oct 2016.